Browse the evidence

Obstructive sleep apnea (OSA) and obesity are highly prevalent and bidirectionally associated.

Healthcare providers should consider the bidirectional relationship when diagnosing and treating patients.

OSA increases the risk of developing comorbid chronic disorders and impairs quality of life.

Clinicians should monitor for chronic disorders in patients with OSA to improve quality of life.

Several studies showed probiotic effectiveness at the species level for specific Blautia species.

Practitioners may consider specific Blautia species as potential probiotics in obesity management.

Obesity is related to a higher incidence of cancer during a lifespan.

Addressing obesity may reduce cancer risk.

Effective treatment of obesity may impact cancer treatment.

Obesity treatment should be considered in cancer care strategies.

Factors associated with remission include shorter duration of diabetes, lower baseline HbA1c, higher baseline BMI, higher BMI reduction at 1 year, and no glucose-lowering drugs at baseline.

Practitioners should consider these factors when assessing remission potential.

New medications for T2DM, such as semaglutide, tirzepatide, and ertugliflozin, have been recently approved.

Healthcare providers should stay informed about newly approved medications for T2DM management.

Managing cardiovascular, renal, and metabolic diseases holistically can lead to improved patient outcomes.

Practitioners should consider integrated care approaches to enhance patient outcomes.

Interdisciplinary team-based care models improve clinical outcomes for patients with cardiovascular, renal, and metabolic diseases.

Healthcare systems should implement interdisciplinary care models to enhance efficiency and patient outcomes.

Continuous glucose monitoring can be used to detect early dysglycemia in individuals with elevated glucose levels.

Practitioners can integrate continuous glucose monitoring into clinical practice to identify prediabetes.

Early detection of dysglycemia can be integrated into clinical practice settings.

Clinicians can adopt continuous glucose monitoring to enhance early detection of dysglycemia.

A 'Westernized athletic diet' may be detrimental to restoring acid-base balance.

Athletes should consider the potential negative effects of high protein and carbohydrate diets on their acid-base balance.

Chronic low-grade metabolic acidosis can have detrimental effects on systemic health, physical performance, and inflammation.

Athletes should be aware that chronic low-grade metabolic acidosis can negatively impact their health and performance.

Ultra-processed foods are associated with poor mental health, aggression, and antisocial behavior.

Practitioners should consider the impact of ultra-processed foods on mental health and behavior.

A holistic approach is important in obesity management, considering individual needs.

Obesity management plans should be tailored to the individual.

Obesity and overweight are linked to a higher risk of asthma.

Practitioners should consider weight management as a factor in asthma risk.

Ultra-processed foods (UPFs) may be associated with obesity and asthma.

Reducing UPF consumption may benefit individuals at risk for obesity and asthma.

The increasing prevalence of non-communicable diseases (NCDs) in the United States is partially attributed to the consumption of ultra-processed foods (UPFs).

Practitioners should consider the role of UPFs in dietary recommendations for preventing NCDs.

Low-carbohydrate, high-protein bread with 5% WSF meets the requirements for low-carbohydrate and high-protein food.

5% WSF can be used to create bread that aligns with low-carb, high-protein dietary goals.

Individual responses to interventions in sport and exercise science vary considerably.

Practitioners should consider individual variability when designing interventions.

Acai supplementation increased Trolox-equivalent antioxidant capacity (TEAC) by 11% after 24 hours compared to placebo.

Acai supplementation may enhance antioxidant capacity in men post-exercise.

The number of Black people who would require a lower dose or be precluded from using a medication increased by 24.7% to 50.2% due to the new eGFR formula.

Healthcare providers should adjust medication dosages for Black patients based on the new eGFR formula.

The changes to the eGFR formula may impact eligibility and/or dosing for antiobesity medications.

Practitioners should be aware of how the new eGFR formula affects treatment options for obesity.

Overweight status (including obesity) is the fourth most common risk factor for non-communicable chronic diseases.

This highlights the importance of addressing obesity in public health initiatives aimed at reducing chronic disease risk.